Drug Survival and Reasons for Discontinuation of the First Course of Biological Therapy in 301 Juvenile Idiopathic Arthritis Patients. Reumatismo 2014, 65 (6), 278-285. https://doi.org/10.4081/reumatismo.2013.682.